BioSpace News Archive

Cerus Corporation (Nasdaq: CERS) today announced the oral presentation of a clinical study: “Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study,” presented by Dr. Nina Khanna of the University Hospital of Basel, Switzerland,

Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, today announced the appointment of Deepa Pakianathan, Ph.D., as an independent member of its Board of Directors.

Sparta Group (TSXV:SAY) (the “Corporation” the “Company”, “Sparta Group”, “Sparta Capital” or “Sparta”) has appointed Mr. Leonard Shara, P.Eng., a chemical engineer with a wide range of technical and business development experience to its Technical Advisory Board.

Olympus Corporation today announced that it has entered into an agreement to acquire Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonolog

Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28.